CYH vs HCA vs SGRY Stock Comparison

Community Health Systems, HCA Healthcare and Surgery Partners Prices as of Nov 13, 2026 Peers: Industry group
HCA HCA Healthcare, Inc.
$499.31 +6.1% 1M +5.5% 1Y
Market cap
$109.44B
P/E
16.2x
Revenue (TTM)
$78.70B
Div. yield
–
Hospitals Healthcare
9 wins
SGRY Surgery Partners, Inc.
$26.95 +81.7% 1M +76.0% 1Y
Market cap
$3.45B
P/E
–
Revenue (TTM)
$3.36B
Div. yield
–
Healthcare Services Healthcare
1 win

Head to Head

11 decided of 12

HCA Healthcare leads on 9 of the 12 questions below (HCA Healthcare 9, Community Health Systems 1, Surgery Partners 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCYHHCASGRYLeader
Larger companyMarket capitalisation $288.70M $109.44B $3.45B HCA
Cheaper on earningsLower P/E, profitable companies only 8.0x 16.2x -39.7x CYH
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 16.2x 74.9x HCA
Faster revenue growthRevenue growth, trailing twelve months -7.8% +5.8% +2.2% HCA
More profitableNet margin, trailing twelve months 0.3% 8.6% -2.6% HCA
Better return on capitalReturn on invested capital 7.0% 21.8% 4.5% HCA
Less leveragedLower net debt / EBITDA 5.5x 3.1x 4.9x HCA
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -33.2% +5.5% +76.0% SGRY
Better 5-year returnAnnualised price return, 5 years -31.5%/yr +15.3%/yr -12.1%/yr HCA
Less volatileAnnualised volatility, 1 year 54.2% 32.7% 61.0% HCA
Higher overall scoreMean of the five percentile scores vs peers 43/100 58/100 47/100 HCA

Percentile Scorecard

CYHHCASGRY

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCYHHCASGRY
Valuation 83 #18 of 99 78 #23 of 99 75 #26 of 99
Growth 8 #82 of 89 24 #68 of 89 19 #72 of 89
Profitability 65 #33 of 92 96 #5 of 92 57 #40 of 92
Financial Health 18 #85 of 103 15 #88 of 103 37 #65 of 103
Shareholder Returns – 81 #13 of 63 –
Overall 43 58 47
  • CYH ranked among 103 companies in Healthcare Providers
  • HCA ranked among 103 companies in Healthcare Providers
  • SGRY ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCYHHCASGRYSPY
1 month -24.9%+6.1%+81.7% -2.0%
3 months -25.9%+23.4%+79.3% -2.8%
6 months -20.9%+18.0%+93.2% +2.0%
Year to date -28.5%+7.0%+74.4% +10.6%
1 year -33.2%+5.5%+76.0% +12.2%
3 years -14.6%+110.2%-10.7% +68.1%
3 years, per year -5.1%+28.1%-3.7% +18.9%
5 years -84.9%+103.6%-47.4% +61.4%
5 years, per year -31.5%+15.3%-12.1% +10.1%
10 years -54.2%+617.6%+79.1% +248.5%
10 years, per year -7.5%+21.8%+6.0% +13.3%

Risk

MeasureCYHHCASGRYSPY
Volatility, 1Y 54.2%32.7%61.0% 13.6%
Downside volatility, 1Y 58.8%30.3%49.3% 13.9%
Beta vs S&P 500, 1Y 1.160.281.06 1.00
Return / volatility, 1Y -0.610.171.25 0.90
Max drawdown, 5Y -86.1%-39.7%-81.4% -25.4%
From 52-week high -42.8%-8.4%0.0% -3.2%
52-week high $3.90$545.13$26.95 $779.14
52-week low $2.05$361.32$11.49 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCYHHCASGRY
P/E now vs peer median 8.4xmedian 22.4x 15.8xmedian 22.4x -39.9xmedian 22.4x
P/S now vs peer median 0.0xmedian 1.3x 1.3xmedian 1.3x 1.0xmedian 1.3x
EV/EBITDA now vs peer median 5.7xmedian 14.2x 9.7xmedian 14.2x 11.3xmedian 14.2x
P/FCF now vs peer median -2.6xmedian 19.0x 17.6xmedian 19.0x 17.4xmedian 19.0x
P/B now vs peer median -0.2xmedian 2.6x -13.0xmedian 2.6x 1.2xmedian 2.6x
PEG now vs peer median -0.18median 0.84 1.09median 0.84 1.13median 0.84

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCYHHCASGRY
Revenue $11.65B $78.70B $3.36B
Gross profit $9.96B $67.30B $747.60M
Operating income $1.27B $12.19B $363.70M
Net income $189.00M $7.80B $1.70M
Free cash flow -$122.00M $5.97B $202.80M
EPS (diluted) $0.27 $31.20 $-0.68
Cash & equivalents $155.00M $908.00M $354.50M
Total debt $9.59B $50.49B $3.06B
Shares (diluted) 135.54M 217.21M 128.87M
Enterprise value -$987.30M $103.81B $2.46B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCYHHCASGRY
P/E 8.4x 15.8x -39.9x
P/FCF -2.6x 17.6x 17.4x
P/Operating cash flow 1.5x 9.4x 12.7x
P/S 0.0x 1.3x 1.0x
P/B -0.2x -13.0x 1.2x
P/Tangible book -0.2x -13.0x 1.2x
EV/EBITDA 5.7x 9.7x 11.3x
EV/EBIT 7.7x 12.7x 17.1x
EV/Revenue 0.8x 2.0x 1.9x
EV/FCF -79.9x 25.9x 30.7x
EV/Operating cash flow 46.2x 13.8x 22.4x
PEG (3Y EPS CAGR) -0.18 1.09 1.13

Growth

14 metrics
MetricCYHHCASGRY
Revenue growth (1Y) -7.8% 5.8% 2.2%
Revenue CAGR (3Y) -2.2% 7.6% 7.4%
Gross profit growth (1Y) -7.1% 6.3% -4.9%
Gross profit CAGR (3Y) -1.6% 8.0% -92.0%
Operating income growth (1Y) -3.9% 6.0% -10.5%
Operating income CAGR (3Y) 13.8% 4.9% 4.3%
Net income growth (1Y) -61.3% 6.8% 102.2%
Net income CAGR (3Y) -20.5% 4.3% -72.9%
EPS growth (1Y) -89.1% 16.1% 49.9%
EPS CAGR (3Y) -47.1% 14.6% -35.3%
Operating cash flow growth (1Y) -57.2% -13.0% -1.6%
Operating cash flow CAGR (3Y) 17.8% 6.4% 5.2%
Free cash flow growth (1Y) -185.3% -26.2% 4.5%
Free cash flow CAGR (3Y) 30.2% 10.9% 11.4%

Profitability

14 metrics
MetricCYHHCASGRY
Gross margin 85.5% 85.5% 22.2%
EBITDA margin 14.6% 20.3% 16.4%
Operating margin 10.9% 15.5% 10.8%
Pretax margin 3.5% 12.5% 2.7%
Net margin 0.3% 8.6% -2.6%
FCF margin -1.0% 7.6% 6.0%
Operating cash flow margin 1.8% 14.2% 8.3%
Return on equity – – 2.4%
Return on assets 1.6% 12.3% 0.9%
Return on invested capital 7.0% 21.8% 4.5%
Return on capital employed 12.5% 28.0% 5.2%
Asset turnover 1.0x 1.2x 0.4x
Cash conversion (OCF / net income) 1.1x 1.4x 163.5x
Stock comp / revenue 0.1% 0.5% 0.4%

Financial Health

11 metrics
MetricCYHHCASGRY
Debt / assets 79.2% 79.6% 43.3%
Debt / equity -6.4x -6.3x 1.1x
Net debt / EBITDA 5.5x 3.1x 4.9x
Debt / FCF -78.6x 8.5x 15.1x
Liabilities / assets 112.3% 112.7% 58.9%
Equity / assets -12.3% -12.7% 41.1%
Interest coverage 1.5x 5.2x –
Current ratio 1.5x 0.8x 2.2x
Quick ratio 1.1x 0.7x 1.6x
Cash ratio 0.1x 0.1x 0.7x
Altman Z-score 1.00 2.52 1.08

Shareholder Returns

7 metrics
MetricCYHHCASGRY
Dividend yield – 0.6% –
Net buyback yield – 8.7% –
Shareholder yield 0.0% 9.3% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCYHHCASGRY
Forward P/E – 16.2xFY2026 74.9xFY2026
EPS, next fiscal year $-1.33FY2026 $30.83FY2026 $0.36FY2026
EPS growth, next FY -211.8%FY2026 +9.3%FY2026 -23.4%FY2026
EPS growth, the year after – +6.2% -22.2%
Revenue, next fiscal year $11.83BFY2026 $73.66BFY2026 $3.31BFY2026
Revenue growth, next FY -5.2%FY2026 -2.6%FY2026 0.0%FY2026
Revenue growth, the year after +0.6% +18.0% -7.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCYHHCASGRY
Held by institutions 82.1% 59.5% 100.0%
Institutions holding 179 1,339 191
Change in shares held, QoQ +6.6% +0.3% -0.8%
Institutions buying 96 569 113
Institutions selling 52 565 50
Buyers to sellers 1.85 1.01 2.26

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CYHHCASGRY
CYH 1.00 0.29 0.23
HCA 0.29 1.00 0.22
SGRY 0.23 0.22 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CYH, HCA and SGRY?

HCA Healthcare (HCA) is the largest by market capitalisation: Community Health Systems (CYH) $288.70M, HCA Healthcare (HCA) $109.44B, Surgery Partners (SGRY) $3.45B.

Which stock is cheaper, CYH, HCA and SGRY?

Community Health Systems (CYH) trades on the lowest price-to-earnings ratio (Community Health Systems (CYH) 8.0x, HCA Healthcare (HCA) 16.2x, Surgery Partners (SGRY) -39.7x). On next year's consensus earnings, HCA Healthcare (HCA) is cheapest (HCA Healthcare (HCA) 16.2x, Surgery Partners (SGRY) 74.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

HCA Healthcare (HCA) grew revenue fastest over the trailing twelve months: Community Health Systems (CYH) -7.8%, HCA Healthcare (HCA) +5.8%, Surgery Partners (SGRY) +2.2%.

Which company is more profitable?

HCA Healthcare (HCA) has the highest net margin (Community Health Systems (CYH) 0.3%, HCA Healthcare (HCA) 8.6%, Surgery Partners (SGRY) -2.6%). On return on invested capital, HCA Healthcare (HCA) leads (Community Health Systems (CYH) 7.0%, HCA Healthcare (HCA) 21.8%, Surgery Partners (SGRY) 4.5%).

Which stock has performed better?

Over the past year Surgery Partners (SGRY) returned the most: Community Health Systems (CYH) -33.2%, HCA Healthcare (HCA) +5.5%, Surgery Partners (SGRY) +76.0%. Over five years, HCA Healthcare (HCA) compounded fastest (Community Health Systems (CYH) -31.5%/yr, HCA Healthcare (HCA) +15.3%/yr, Surgery Partners (SGRY) -12.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, HCA Healthcare (HCA) has been the steadiest (Community Health Systems (CYH) 54.2%, HCA Healthcare (HCA) 32.7%, Surgery Partners (SGRY) 61.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CYH, HCA and SGRY?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, HCA Healthcare (HCA) leads on 9. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.